HEADER TRANSFERASE 17-JUN-11 3SI0 TITLE STRUCTURE OF GLYCOSYLATED HUMAN GLUTAMINYL CYCLASE COMPND MOL_ID: 1; COMPND 2 MOLECULE: GLUTAMINYL-PEPTIDE CYCLOTRANSFERASE; COMPND 3 CHAIN: A; COMPND 4 FRAGMENT: UNP RESIDUES 38-361; COMPND 5 SYNONYM: GLUTAMINYL CYCLASE, QC, SQC, GLUTAMINYL-TRNA COMPND 6 CYCLOTRANSFERASE, GLUTAMYL CYCLASE, EC; COMPND 7 EC: 2.3.2.5; COMPND 8 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: QPCT; SOURCE 6 EXPRESSION_SYSTEM: PICHIA PASTORIS; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 4922; SOURCE 8 EXPRESSION_SYSTEM_STRAIN: X33; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PPICZALPHAB KEYWDS ALPHA/BETA HYDROLASE, ALZHEIMER'S DISEASE, PYROGLUTAMATE, PGLU, PE, KEYWDS 2 PGLU-AMYLOID, GLYCOSYLATION, GLYCOPROTEIN, TRANSFERASE EXPDTA X-RAY DIFFRACTION AUTHOR C.PARTHIER,D.CARRILLO,M.T.STUBBS REVDAT 8 09-OCT-24 3SI0 1 REMARK REVDAT 7 13-SEP-23 3SI0 1 HETSYN REVDAT 6 29-JUL-20 3SI0 1 COMPND REMARK SEQADV HETNAM REVDAT 6 2 1 LINK SITE ATOM REVDAT 5 08-NOV-17 3SI0 1 REMARK REVDAT 4 31-AUG-11 3SI0 1 AUTHOR REVDAT 3 27-JUL-11 3SI0 1 JRNL REVDAT 2 06-JUL-11 3SI0 1 JRNL REVDAT 1 29-JUN-11 3SI0 0 JRNL AUTH D.RUIZ-CARRILLO,B.KOCH,C.PARTHIER,M.WERMANN,T.DAMBE, JRNL AUTH 2 M.BUCHHOLZ,H.H.LUDWIG,U.HEISER,J.U.RAHFELD,M.T.STUBBS, JRNL AUTH 3 S.SCHILLING,H.U.DEMUTH JRNL TITL STRUCTURES OF GLYCOSYLATED MAMMALIAN GLUTAMINYL CYCLASES JRNL TITL 2 REVEAL CONFORMATIONAL VARIABILITY NEAR THE ACTIVE CENTER. JRNL REF BIOCHEMISTRY V. 50 6280 2011 JRNL REFN ISSN 0006-2960 JRNL PMID 21671571 JRNL DOI 10.1021/BI200249H REMARK 2 REMARK 2 RESOLUTION. 2.10 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : REFMAC REMARK 3 AUTHORS : MURSHUDOV,SKUBAK,LEBEDEV,PANNU,STEINER, REMARK 3 : NICHOLLS,WINN,LONG,VAGIN REMARK 3 REMARK 3 REFINEMENT TARGET : MAXIMUM LIKELIHOOD REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.10 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 11.98 REMARK 3 DATA CUTOFF (SIGMA(F)) : NULL REMARK 3 COMPLETENESS FOR RANGE (%) : 95.4 REMARK 3 NUMBER OF REFLECTIONS : 20342 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING + TEST SET) : 0.207 REMARK 3 R VALUE (WORKING SET) : 0.204 REMARK 3 FREE R VALUE : 0.264 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.000 REMARK 3 FREE R VALUE TEST SET COUNT : 1073 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 20 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.10 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.15 REMARK 3 REFLECTION IN BIN (WORKING SET) : 1458 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 95.40 REMARK 3 BIN R VALUE (WORKING SET) : 0.2870 REMARK 3 BIN FREE R VALUE SET COUNT : 78 REMARK 3 BIN FREE R VALUE : 0.3170 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 2536 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 35 REMARK 3 SOLVENT ATOMS : 150 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : NULL REMARK 3 MEAN B VALUE (OVERALL, A**2) : 36.95 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -1.02000 REMARK 3 B22 (A**2) : -3.81000 REMARK 3 B33 (A**2) : 5.95000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 2.05000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED OVERALL COORDINATE ERROR. REMARK 3 ESU BASED ON R VALUE (A): 0.237 REMARK 3 ESU BASED ON FREE R VALUE (A): 0.209 REMARK 3 ESU BASED ON MAXIMUM LIKELIHOOD (A): 0.173 REMARK 3 ESU FOR B VALUES BASED ON MAXIMUM LIKELIHOOD (A**2): 13.960 REMARK 3 REMARK 3 CORRELATION COEFFICIENTS. REMARK 3 CORRELATION COEFFICIENT FO-FC : 0.949 REMARK 3 CORRELATION COEFFICIENT FO-FC FREE : 0.911 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES COUNT RMS WEIGHT REMARK 3 BOND LENGTHS REFINED ATOMS (A): 2641 ; 0.023 ; 0.021 REMARK 3 BOND LENGTHS OTHERS (A): NULL ; NULL ; NULL REMARK 3 BOND ANGLES REFINED ATOMS (DEGREES): 3591 ; 1.996 ; 1.970 REMARK 3 BOND ANGLES OTHERS (DEGREES): NULL ; NULL ; NULL REMARK 3 TORSION ANGLES, PERIOD 1 (DEGREES): 311 ; 7.344 ; 5.000 REMARK 3 TORSION ANGLES, PERIOD 2 (DEGREES): 131 ;34.838 ;23.969 REMARK 3 TORSION ANGLES, PERIOD 3 (DEGREES): 426 ;17.344 ;15.000 REMARK 3 TORSION ANGLES, PERIOD 4 (DEGREES): 16 ;22.096 ;15.000 REMARK 3 CHIRAL-CENTER RESTRAINTS (A**3): 391 ; 0.129 ; 0.200 REMARK 3 GENERAL PLANES REFINED ATOMS (A): 2041 ; 0.010 ; 0.021 REMARK 3 GENERAL PLANES OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED CONTACTS OTHERS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 NON-BONDED TORSION OTHERS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 H-BOND (X...Y) OTHERS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 POTENTIAL METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY VDW OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY H-BOND OTHERS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION REFINED ATOMS (A): NULL ; NULL ; NULL REMARK 3 SYMMETRY METAL-ION OTHERS (A): NULL ; NULL ; NULL REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 MAIN-CHAIN BOND REFINED ATOMS (A**2): 1572 ; 0.971 ; 1.500 REMARK 3 MAIN-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 MAIN-CHAIN ANGLE REFINED ATOMS (A**2): 2536 ; 1.540 ; 2.000 REMARK 3 MAIN-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN BOND REFINED ATOMS (A**2): 1069 ; 2.603 ; 3.000 REMARK 3 SIDE-CHAIN BOND OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SIDE-CHAIN ANGLE REFINED ATOMS (A**2): 1055 ; 3.805 ; 4.500 REMARK 3 SIDE-CHAIN ANGLE OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B REFINED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 LONG RANGE B OTHER ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 ANISOTROPIC THERMAL FACTOR RESTRAINTS. COUNT RMS WEIGHT REMARK 3 RIGID-BOND RESTRAINTS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; FREE ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 SPHERICITY; BONDED ATOMS (A**2): NULL ; NULL ; NULL REMARK 3 REMARK 3 NCS RESTRAINTS STATISTICS REMARK 3 NUMBER OF DIFFERENT NCS GROUPS : NULL REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : 1 REMARK 3 REMARK 3 TLS GROUP : 1 REMARK 3 NUMBER OF COMPONENTS GROUP : 1 REMARK 3 COMPONENTS C SSSEQI TO C SSSEQI REMARK 3 RESIDUE RANGE : A 38 A 361 REMARK 3 ORIGIN FOR THE GROUP (A): -9.0260 -18.2220 -22.8760 REMARK 3 T TENSOR REMARK 3 T11: 0.2844 T22: 0.2906 REMARK 3 T33: 0.0733 T12: 0.0094 REMARK 3 T13: 0.0172 T23: -0.0322 REMARK 3 L TENSOR REMARK 3 L11: 1.8603 L22: 2.6312 REMARK 3 L33: 1.6257 L12: 0.3079 REMARK 3 L13: -0.2014 L23: 0.2900 REMARK 3 S TENSOR REMARK 3 S11: 0.0355 S12: -0.2392 S13: 0.2273 REMARK 3 S21: 0.3619 S22: -0.0770 S23: 0.3767 REMARK 3 S31: 0.0116 S32: -0.1232 S33: 0.0415 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : MASK REMARK 3 PARAMETERS FOR MASK CALCULATION REMARK 3 VDW PROBE RADIUS : 1.40 REMARK 3 ION PROBE RADIUS : 0.80 REMARK 3 SHRINKAGE RADIUS : 0.80 REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: HYDROGENS HAVE BEEN ADDED IN THE RIDING REMARK 3 POSITIONS REMARK 4 REMARK 4 3SI0 COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 20-JUN-11. REMARK 100 THE DEPOSITION ID IS D_1000066226. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 26-MAY-09 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 8 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : BESSY REMARK 200 BEAMLINE : 14.1 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 0.9184 REMARK 200 MONOCHROMATOR : BL 14.1 REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : RAYONIX MX-225 REMARK 200 INTENSITY-INTEGRATION SOFTWARE : XSCALE REMARK 200 DATA SCALING SOFTWARE : SCALA 3.3.15, XSCALE REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 21435 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.100 REMARK 200 RESOLUTION RANGE LOW (A) : 11.981 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 0.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 200 DATA REDUNDANCY : 3.000 REMARK 200 R MERGE (I) : NULL REMARK 200 R SYM (I) : 0.08900 REMARK 200 FOR THE DATA SET : 7.1000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.10 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.21 REMARK 200 COMPLETENESS FOR SHELL (%) : 96.3 REMARK 200 DATA REDUNDANCY IN SHELL : 2.60 REMARK 200 R MERGE FOR SHELL (I) : 0.40900 REMARK 200 R SYM FOR SHELL (I) : 0.40900 REMARK 200 FOR SHELL : 1.900 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: PHASER REMARK 200 STARTING MODEL: PDB ENTRY 2AFM REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 52.21 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.57 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 100 MM IMIDAZOLE, 30% V/V MPD, 11% W/V REMARK 280 PEG4000, PH 8, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 294K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: C 1 2 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y,-Z REMARK 290 3555 X+1/2,Y+1/2,Z REMARK 290 4555 -X+1/2,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 SMTRY1 3 1.000000 0.000000 0.000000 41.20400 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 31.84400 REMARK 290 SMTRY3 3 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 4 -1.000000 0.000000 0.000000 41.20400 REMARK 290 SMTRY2 4 0.000000 1.000000 0.000000 31.84400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: MONOMERIC REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 375 REMARK 375 SPECIAL POSITION REMARK 375 THE FOLLOWING ATOMS ARE FOUND TO BE WITHIN 0.15 ANGSTROMS REMARK 375 OF A SYMMETRY RELATED ATOM AND ARE ASSUMED TO BE ON SPECIAL REMARK 375 POSITIONS. REMARK 375 REMARK 375 ATOM RES CSSEQI REMARK 375 HOH A 485 LIES ON A SPECIAL POSITION. REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 HIS A 32 REMARK 465 HIS A 33 REMARK 465 HIS A 34 REMARK 465 HIS A 35 REMARK 465 HIS A 36 REMARK 465 HIS A 37 REMARK 465 SER A 147 REMARK 465 HIS A 148 REMARK 465 TRP A 149 REMARK 465 THR A 183 REMARK 465 VAL A 184 REMARK 465 SER A 185 REMARK 465 ASP A 186 REMARK 465 SER A 187 REMARK 465 LYS A 188 REMARK 465 PRO A 189 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: CLOSE CONTACTS IN SAME ASYMMETRIC UNIT REMARK 500 REMARK 500 THE FOLLOWING ATOMS ARE IN CLOSE CONTACT. REMARK 500 REMARK 500 ATM1 RES C SSEQI ATM2 RES C SSEQI DISTANCE REMARK 500 OE1 GLU A 76 O HOH A 443 2.17 REMARK 500 O HOH A 444 O HOH A 454 2.18 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND LENGTHS REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,2(A3,1X,A1,I4,A1,1X,A4,3X),1X,F6.3) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 RES CSSEQI ATM2 DEVIATION REMARK 500 GLU A 105 CB GLU A 105 CG 0.126 REMARK 500 TYR A 214 CD1 TYR A 214 CE1 0.145 REMARK 500 TYR A 214 CE2 TYR A 214 CD2 0.098 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: COVALENT BOND ANGLES REMARK 500 REMARK 500 THE STEREOCHEMICAL PARAMETERS OF THE FOLLOWING RESIDUES REMARK 500 HAVE VALUES WHICH DEVIATE FROM EXPECTED VALUES BY MORE REMARK 500 THAN 6*RMSD (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 500 IDENTIFIER; SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT: (10X,I3,1X,A3,1X,A1,I4,A1,3(1X,A4,2X),12X,F5.1) REMARK 500 REMARK 500 EXPECTED VALUES PROTEIN: ENGH AND HUBER, 1999 REMARK 500 EXPECTED VALUES NUCLEIC ACID: CLOWNEY ET AL 1996 REMARK 500 REMARK 500 M RES CSSEQI ATM1 ATM2 ATM3 REMARK 500 PRO A 72 C - N - CA ANGL. DEV. = -10.0 DEGREES REMARK 500 ARG A 88 NE - CZ - NH2 ANGL. DEV. = -3.5 DEGREES REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ARG A 77 49.28 -145.79 REMARK 500 ALA A 100 145.22 -38.31 REMARK 500 ASN A 151 39.70 71.56 REMARK 500 SER A 160 41.49 -152.03 REMARK 500 LEU A 181 5.50 -64.98 REMARK 500 ASP A 211 79.36 -114.09 REMARK 500 SER A 212 162.27 163.48 REMARK 500 ASP A 306 -19.34 -48.99 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: NON-CIS, NON-TRANS REMARK 500 REMARK 500 THE FOLLOWING PEPTIDE BONDS DEVIATE SIGNIFICANTLY FROM BOTH REMARK 500 CIS AND TRANS CONFORMATION. CIS BONDS, IF ANY, ARE LISTED REMARK 500 ON CISPEP RECORDS. TRANS IS DEFINED AS 180 +/- 30 AND REMARK 500 CIS IS DEFINED AS 0 +/- 30 DEGREES. REMARK 500 MODEL OMEGA REMARK 500 ASN A 150 ASN A 151 -149.96 REMARK 500 REMARK 500 REMARK: NULL REMARK 620 REMARK 620 METAL COORDINATION REMARK 620 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 620 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE): REMARK 620 REMARK 620 COORDINATION ANGLES FOR: M RES CSSEQI METAL REMARK 620 ZN A 362 ZN REMARK 620 N RES CSSEQI ATOM REMARK 620 1 ASP A 159 OD1 REMARK 620 2 ASP A 159 OD2 56.8 REMARK 620 3 GLU A 202 OE2 112.3 91.0 REMARK 620 4 HIS A 330 NE2 106.6 163.0 99.7 REMARK 620 5 IMD A 363 N3 127.4 85.4 102.4 104.9 REMARK 620 N 1 2 3 4 REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: 3SI1 RELATED DB: PDB REMARK 900 STRUCTURE OF GLYCOSYLATED MURINE GLUTAMINYL CYCLASE REMARK 900 RELATED ID: 3SI2 RELATED DB: PDB REMARK 900 STRUCTURE OF GLYCOSYLATED MURINE GLUTAMINYL CYCLASE IN PRESENCE OF REMARK 900 THE INHIBITOR PQ50 (PDBD150) DBREF 3SI0 A 38 361 UNP Q16769 QPCT_HUMAN 38 361 SEQADV 3SI0 HIS A 32 UNP Q16769 EXPRESSION TAG SEQADV 3SI0 HIS A 33 UNP Q16769 EXPRESSION TAG SEQADV 3SI0 HIS A 34 UNP Q16769 EXPRESSION TAG SEQADV 3SI0 HIS A 35 UNP Q16769 EXPRESSION TAG SEQADV 3SI0 HIS A 36 UNP Q16769 EXPRESSION TAG SEQADV 3SI0 HIS A 37 UNP Q16769 EXPRESSION TAG SEQRES 1 A 330 HIS HIS HIS HIS HIS HIS GLU GLU LYS ASN TYR HIS GLN SEQRES 2 A 330 PRO ALA ILE LEU ASN SER SER ALA LEU ARG GLN ILE ALA SEQRES 3 A 330 GLU GLY THR SER ILE SER GLU MET TRP GLN ASN ASP LEU SEQRES 4 A 330 GLN PRO LEU LEU ILE GLU ARG TYR PRO GLY SER PRO GLY SEQRES 5 A 330 SER TYR ALA ALA ARG GLN HIS ILE MET GLN ARG ILE GLN SEQRES 6 A 330 ARG LEU GLN ALA ASP TRP VAL LEU GLU ILE ASP THR PHE SEQRES 7 A 330 LEU SER GLN THR PRO TYR GLY TYR ARG SER PHE SER ASN SEQRES 8 A 330 ILE ILE SER THR LEU ASN PRO THR ALA LYS ARG HIS LEU SEQRES 9 A 330 VAL LEU ALA CYS HIS TYR ASP SER LYS TYR PHE SER HIS SEQRES 10 A 330 TRP ASN ASN ARG VAL PHE VAL GLY ALA THR ASP SER ALA SEQRES 11 A 330 VAL PRO CYS ALA MET MET LEU GLU LEU ALA ARG ALA LEU SEQRES 12 A 330 ASP LYS LYS LEU LEU SER LEU LYS THR VAL SER ASP SER SEQRES 13 A 330 LYS PRO ASP LEU SER LEU GLN LEU ILE PHE PHE ASP GLY SEQRES 14 A 330 GLU GLU ALA PHE LEU HIS TRP SER PRO GLN ASP SER LEU SEQRES 15 A 330 TYR GLY SER ARG HIS LEU ALA ALA LYS MET ALA SER THR SEQRES 16 A 330 PRO HIS PRO PRO GLY ALA ARG GLY THR SER GLN LEU HIS SEQRES 17 A 330 GLY MET ASP LEU LEU VAL LEU LEU ASP LEU ILE GLY ALA SEQRES 18 A 330 PRO ASN PRO THR PHE PRO ASN PHE PHE PRO ASN SER ALA SEQRES 19 A 330 ARG TRP PHE GLU ARG LEU GLN ALA ILE GLU HIS GLU LEU SEQRES 20 A 330 HIS GLU LEU GLY LEU LEU LYS ASP HIS SER LEU GLU GLY SEQRES 21 A 330 ARG TYR PHE GLN ASN TYR SER TYR GLY GLY VAL ILE GLN SEQRES 22 A 330 ASP ASP HIS ILE PRO PHE LEU ARG ARG GLY VAL PRO VAL SEQRES 23 A 330 LEU HIS LEU ILE PRO SER PRO PHE PRO GLU VAL TRP HIS SEQRES 24 A 330 THR MET ASP ASP ASN GLU GLU ASN LEU ASP GLU SER THR SEQRES 25 A 330 ILE ASP ASN LEU ASN LYS ILE LEU GLN VAL PHE VAL LEU SEQRES 26 A 330 GLU TYR LEU HIS LEU MODRES 3SI0 ASN A 49 ASN GLYCOSYLATION SITE HET NAG B 1 14 HET NAG B 2 14 HET ZN A 362 1 HET IMD A 363 5 HET CL A 364 1 HETNAM NAG 2-ACETAMIDO-2-DEOXY-BETA-D-GLUCOPYRANOSE HETNAM ZN ZINC ION HETNAM IMD IMIDAZOLE HETNAM CL CHLORIDE ION HETSYN NAG N-ACETYL-BETA-D-GLUCOSAMINE; 2-ACETAMIDO-2-DEOXY-BETA- HETSYN 2 NAG D-GLUCOSE; 2-ACETAMIDO-2-DEOXY-D-GLUCOSE; 2-ACETAMIDO- HETSYN 3 NAG 2-DEOXY-GLUCOSE; N-ACETYL-D-GLUCOSAMINE FORMUL 2 NAG 2(C8 H15 N O6) FORMUL 3 ZN ZN 2+ FORMUL 4 IMD C3 H5 N2 1+ FORMUL 5 CL CL 1- FORMUL 6 HOH *150(H2 O) HELIX 1 1 GLU A 38 HIS A 43 1 6 HELIX 2 2 ASN A 49 THR A 60 1 12 HELIX 3 3 SER A 61 ASP A 69 1 9 HELIX 4 4 LEU A 70 LEU A 74 5 5 HELIX 5 5 SER A 81 ARG A 97 1 17 HELIX 6 6 SER A 160 LEU A 174 1 15 HELIX 7 7 LEU A 174 SER A 180 1 7 HELIX 8 8 LEU A 213 SER A 225 1 13 HELIX 9 9 GLN A 237 HIS A 239 5 3 HELIX 10 10 PHE A 261 ASN A 263 5 3 HELIX 11 11 SER A 264 LEU A 281 1 18 HELIX 12 12 HIS A 307 ARG A 312 1 6 HELIX 13 13 ASP A 340 LEU A 359 1 20 SHEET 1 A 6 VAL A 103 SER A 111 0 SHEET 2 A 6 ARG A 118 THR A 126 -1 O THR A 126 N VAL A 103 SHEET 3 A 6 LEU A 191 PHE A 198 -1 O LEU A 195 N SER A 125 SHEET 4 A 6 ARG A 133 HIS A 140 1 N LEU A 137 O ILE A 196 SHEET 5 A 6 MET A 241 LEU A 247 1 O LEU A 247 N ALA A 138 SHEET 6 A 6 VAL A 317 LEU A 320 1 O LEU A 318 N LEU A 244 SHEET 1 B 2 PHE A 257 ASN A 259 0 SHEET 2 B 2 PHE A 294 SER A 298 1 O TYR A 297 N ASN A 259 SSBOND 1 CYS A 139 CYS A 164 1555 1555 2.16 LINK ND2 ASN A 49 C1 NAG B 1 1555 1555 1.44 LINK O4 NAG B 1 C1 NAG B 2 1555 1555 1.45 LINK OD1 ASP A 159 ZN ZN A 362 1555 1555 1.97 LINK OD2 ASP A 159 ZN ZN A 362 1555 1555 2.54 LINK OE2 GLU A 202 ZN ZN A 362 1555 1555 1.98 LINK NE2 HIS A 330 ZN ZN A 362 1555 1555 2.14 LINK ZN ZN A 362 N3 IMD A 363 1555 1555 1.84 CISPEP 1 ASP A 159 SER A 160 0 12.60 CISPEP 2 HIS A 228 PRO A 229 0 -11.06 CISPEP 3 SER A 323 PRO A 324 0 8.10 CRYST1 82.408 63.688 77.159 90.00 105.76 90.00 C 1 2 1 4 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.012135 0.000000 0.003425 0.00000 SCALE2 0.000000 0.015702 0.000000 0.00000 SCALE3 0.000000 0.000000 0.013466 0.00000